• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Clinical Research | Clinical Trials & Recruitment | News, Analysis - HIT Consultant

AI/ML Used for Clinical Trial-Site Identification Simultaneously Improves Enrollment Rates and Diversity

by Lucas Glass, VP of the Analytics Center of Excellence (ACOE), IQVIA 12/12/2022 Leave a Comment

AI/ML Used for Clinical Trial-Site Identification Simultaneously Improves Enrollment Rates and Diversity

Ethnic and racial minorities are commonly underrepresented in clinical trials. This problem is so severe that in April, the U.S. Food and Drug Administration (FDA) expanded upon existing guidance to further emphasize recommendations to sponsors developing treatments to increase enrollment from underrepresented populations in the U.S., including African-American, Hispanic, Asian and other persons of color, in clinical trials. In the updated guidance, the FDA provided details on what sponsors
Read More

GDIT Awarded $84M Traumatic Brain Injury Research Contract by the Defense Health Agency

by Jasmine Pennic 12/07/2022 Leave a Comment

GDIT Awarded $84M Traumatic Brain Injury Research Contract by the Defense Health Agency

What You Should Know: - General Dynamics Information Technology (GDIT), a business unit of General Dynamics (NYSE:GD), announced today that it was awarded an $84 million contract by the Defense Health Agency (DHA) to support the Traumatic Brain Injury Center of Excellence (TBICoE). The contract has an eight-month base period with three option years. - Under the contract, GDIT will continue to support the TBICoE in conducting clinical
Read More

How Virtual-First Clinical Trials Scale Access for Participants

by Rachael Scott, Chief Commercial Officer, Lightship 12/06/2022 Leave a Comment

How Virtual-First Clinical Trials Scale Access for Participants

Making clinical trials equitable is one of the biggest challenges we face as an industry. We see this time and again, with one of the latest examples coming in the form of a study published in JAMA Network Open that found substantial underrepresentation of Black patients enrolled in pivotal trials for CAR-T therapy.   Women are another demographic negatively affected by inequality in clinical research. Earlier this month [May 2022] the American Heart Association issued a
Read More

Lumen Raises $62M for Handheld Device to Measure Metabolic Health

by Syed Hamza Sohail 12/01/2022 Leave a Comment

Lumen Raises $62M to Empower People to Optimize Metabolic Health

What You Should Know: - Lumen, the metabolic health company behind the first handheld device to measure your metabolism through the breath, today announced that it has raised $62M in a series B funding round led by Pitango Venture Capital. - Participating investors include Hanwha Group, Resolute Ventures, RiverPark Ventures, Unorthodox Ventures, Almeda Capital, and Disruptive VC. World’s Largest Platform For Measuring Metabolism To Expand Business Growth and Research Lumen helps
Read More

UCLA Spinout PictorLabs Launches with $18.8M to Revolutionize Histopathology

by Syed Hamza Sohail 12/01/2022 Leave a Comment

UCLA Spinout PictorLabs Launches with $18.8M to Advance Transformative Virtual Staining

What You Should Know: - PictorLabs launches with more than $18M in financing to advance an AI-powered virtual staining platform to revolutionize histopathology, an area that has seen little change in over a century and is essential for clinical research and patient diagnoses. Investors include M Venture (Merck's corporate VC arm), SSC Soft Computer, and Koç Holding. - Spun out of UCLA, PictorLabs replaces complex chemical-based tissue staining processes (which are time-consuming to
Read More

Site Enablement Platforms Can Accelerate Clinical Trials by 6  Weeks and Reduce Costs by Over $1M

by Syed Hamza Sohail 11/23/2022 Leave a Comment

Site Enablement Platforms Can Accelerate Clinical Trials by 6 Weeks and Reduce Costs by Over $1M

What You Should Know: - Florence HealthcareTM, a clinical research technology company headquartered in Atlanta, Georgia, recently announced the completion of a year-long third-party study on the impact of Site Enablement PlatformsTM on clinical research timelines and costs.  - The study by Marketcap Consulting is the first to compare how traditional site management approaches differ from site-first Site Enablement Platforms. The study looked at the impact of traditional sponsor
Read More

HLTH22 Day 1 News Summary: Google, Maven, Highmark, LG, Others

by Fred Pennic 11/14/2022 Leave a Comment

17 HLTH 2022 Predictions from Digital Health Executives to Watch

Venture Capital, Private Equity Funding Maven Clinic Secures $90M to Advance End-to-End Family Care Platform Maven Clinic, the largest virtual clinic in women’s and family health raises $90 million Series E funding bringing its total funding to $300M. Maven plans to use the latest round of funding to advance its end-to-end family care platform to enable deeper personalization to meet the diverse needs of women and families everywhere. Curavit Raises $5M for Digital Therapeutics
Read More

HLTH22: Curavit Raises $5M for Digital Therapeutics Clinical Research

by Fred Pennic 11/14/2022 Leave a Comment

Curavit Raises $5M for Digital Therapeutics Clinical Research

What You Should Know: - Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) announced it raised $5M in Series A funding to accelerate its growing portfolio of research in the global digital therapeutics (DTx) market. The round was led by  Osage Venture Partners with additional investment from Royal Street Ventures and Narrow Gauge Ventures.  - The new funding will be used to expand
Read More

21st Century Pregnancy Care: Unleashing The Power of RNA

by Dr. Alison Cowan, Practicing OB/GYN & Head of Medical Affairs at Mirvie 11/14/2022 Leave a Comment

21st Century Pregnancy Care: Unleashing The Power of RNA

While maternal mortality is on the rise in the U.S., pregnancy health has seen little innovation in understanding the underlying biology of disease and is ripe for change. Nowhere is this more evident than in the realm of the prediction of preeclampsia. Fortunately, with new technology on the horizon, doctors will finally be able to predict preeclampsia and other pregnancy complications before they arise by evaluating the underlying biology of each pregnancy expressed through RNA messages.
Read More

Komodo Health & Intercept Partner to Study Rare Liver Disease

by Jasmine Pennic 11/11/2022 Leave a Comment

Komodo Health

What You Should Know: - Komodo Health announced its collaboration with Intercept Pharmaceuticals to power clinical research and new real-world evidence (RWE) with Komodo’s platform.  Leveraging Komodo’s tech platform and Healthcare Map, Intercept was able to conduct a retrospective real-world study on the long term outcomes for Ocaliva — a therapeutic for rare liver disease, primary biliary cholangitis (PBC).  Partnership Details Intercept initially developed a traditional
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 17
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |